GeoHAI App for Healthcare-Associated Infections
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new computer app called GeoHAI, designed to help prevent hospital-acquired infections (HAIs). The app uses mapping and geographic data to identify infection clusters and assess how infections spread in hospitals. The goal is to enhance the speed and effectiveness of infection preventionists' responses to HAIs. Infection preventionists or physicians involved in infection prevention at the participating health system may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative solutions in infection prevention.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the GeoHAI app is safe for use in hospitals?
Research has shown that the GeoHAI app helps control hospital-acquired infections by using location data. Researchers are testing the app to determine its safety and effectiveness for patients. The study is labeled "Not Applicable" in phase, indicating that the app is neither a drug nor a medical treatment. Instead, it uses data to prevent infections, eliminating side effects or risks associated with medicines. The focus is on how well the app aids hospital staff in tracking and preventing infections, rather than any direct impact on patients' health.12345
Why are researchers excited about this trial?
Researchers are excited about the GeoHAI app because it offers a novel approach to managing healthcare-associated infections. Unlike traditional methods, which often involve manual tracking and reporting, GeoHAI leverages cutting-edge technology to provide real-time data and insights. This tool could significantly enhance infection control by enabling quicker responses and more accurate intervention strategies, potentially reducing infection rates in healthcare settings.
What evidence suggests that the GeoHAI app is effective for preventing hospital-acquired infections?
Research has shown that electronic tools, such as apps, can help identify and reduce hospital-acquired infections. In this trial, participants will use GeoHAI, a tool designed to help infection experts track the spread of infections over time and within hospitals. Studies have found that AI-powered tools like GeoHAI effectively predict and identify these infections. By using location information, GeoHAI pinpoints where infections occur and how they spread. This can lead to quicker responses and improved infection prevention methods in hospitals.23678
Who Is on the Research Team?
Courtney Hebert, MD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for infection preventionists and physicians who are involved in infection control at the participating health system. It's not open to those who aren't in this role or don't work within the specified healthcare setting.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants are trained on how to use the GeoHAI tool
Implementation
Participants use the GeoHAI tool to identify HAI clusters and assess transmission risk
Follow-up
Participants are monitored for changes in HAI investigation processes and tool usability
What Are the Treatments Tested in This Trial?
Interventions
- GeoHAI
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
University of Florida
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator